cd38 inhibitor and 5-amino-1mq synergy nad+ CD38-expressing macrophages drive age-related decline CD38-Induced Metabolic Dysfunction Primes Multiple
CD38 Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+ Lowering Agents Heavy chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs Scientific Reports Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect Inhibition of CD38 by 78c Enhanced NAD+, Alleviated Inflammation, and Decreased Oxidative Stress in Old Murine Macrophages Induced by Oral Pathogens CD38 as theranostic target in oncology Journal of Translational Medicine Springer Nature Link Inhibition of CD38 enzymatic activity enhances CAR T cell immune therapeutic efficacy by repressing glycolytic metabolism ScienceDirect
Pay in 4 interest-free payments of $7.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





